• HyperScript First-Strand cDNA Synthesis Kit: Applied Workflo

  2026-04-28

  Unlock robust first-strand cDNA synthesis from even the most challenging RNA templates with the HyperScript First-Strand cDNA Synthesis Kit. From low-copy gene quantification to complex secondary structure handling, this APExBIO solution delivers reproducibility and sensitivity—making it ideal for advanced transcriptomics and clinical biomarker studies.

• Elobixibat Hydrate: Applied Workflows for GI and Metabolic R

  2026-04-28

  Elobixibat hydrate, a selective ileal bile acid transporter inhibitor, enables highly reproducible experimental workflows for chronic idiopathic constipation and metabolic dysfunction models. This article delivers hands-on protocol enhancements, troubleshooting strategies, and advanced applications for translational and preclinical studies with APExBIO's Elobixibat hydrate.

• Selective FGFR1 Inhibition: Insights from PD 173074 in Neuro

  2026-04-27

  This study establishes PD 173074 as a potent and selective FGFR1 kinase inhibitor capable of antagonizing FGF-2-mediated neurotrophic and neurotropic effects. By demonstrating nanomolar efficacy and high selectivity in neuronal survival and neurite outgrowth assays, the work provides a robust foundation for dissecting FGFR signaling in neurobiology and beyond.

• Synergistic Induction of Cell Death in RCC via SGI-1027 and

  2026-04-27

  This study demonstrates that the DNMT1 inhibitor SGI-1027, when combined with everolimus, induces methuosis, apoptosis, and pyroptosis in renal cell carcinoma by increasing lysosomal membrane permeability. The findings suggest a novel strategy to overcome everolimus resistance and improve therapeutic outcomes in advanced RCC.

• Annexin A7 Controls TIA1 Axonal Trafficking and Aggregation

  2026-04-26

  This study elucidates how Annexin A7 facilitates the retrograde transport of TIA1-containing ribonucleoprotein complexes (RNPs) in neurons, preventing their pathological aggregation. The findings provide mechanistic insight into axonal RNP trafficking and suggest new avenues for investigating neurodegeneration.

• NLRP10 Regulates Keratinocyte Survival and Differentiation i

  2026-04-25

  This study uncovers the essential role of NLRP10 in maintaining epidermal homeostasis by promoting keratinocyte survival and P63-mediated differentiation, key processes disrupted in atopic dermatitis. The findings establish NLRP10 as a promising target for restoring skin barrier function and suggest new avenues for patient-specific therapies.

• ARCA EGFP mRNA: Reliable mRNA Transfection Control for Cell

  2026-04-24

  This article delivers scenario-driven guidance for biomedical researchers on leveraging ARCA EGFP mRNA (SKU R1001) as a direct-detection reporter mRNA to optimize fluorescence-based transfection assays and monitor mammalian cell gene expression. Grounded in quantitative performance data and best practices, it addresses common pitfalls in assay reproducibility, protocol optimization, and vendor selection, demonstrating the practical value of ARCA EGFP mRNA in reliable experimental workflows.

• Therapy Sequencing in Waldenström Macroglobulinemia: Insight

  2026-04-24

  This review discusses recent advances in the sequencing of therapies for Waldenström Macroglobulinemia (WM), highlighting the central role of genomic profiling—especially MYD88 and CXCR4 mutations—in guiding treatment. The findings underscore the importance of individualized regimens and outline how workflow optimizations from leukemia research inform experimental model development.

• Belinostat (PXD101) for Epigenetic Cancer Therapy Workflows

  2026-04-23

  Belinostat (PXD101) empowers next-gen cancer research by delivering robust, quantifiable histone deacetylase inhibition and enabling precise modulation of tumor cell proliferation. This guide highlights optimized assay design, practical troubleshooting, and actionable workflow enhancements, all grounded in recent methodological advances.

• Tunable Human Intestinal Organoids: Balancing Self-Renewal a

  2026-04-23

  This study presents a robust organoid culture system that achieves a controlled balance between stem cell self-renewal and differentiation in human intestinal organoids. By using small molecule pathway modulators, the system enables high proliferative capacity and increased cellular diversity without artificial signaling gradients, enhancing organoid scalability for research applications.

• Oseltamivir Acid: Influenza Neuraminidase Inhibitor in Appli

  2026-04-22

  Oseltamivir acid stands out as a versatile influenza neuraminidase inhibitor, driving advances in both antiviral and oncology research. This guide details optimized workflows, practical troubleshooting, and strategic innovations—empowering researchers to harness its full experimental potential.

• Prostaglandin E2: Optimizing Inflammation and GI Research Pr

  2026-04-22

  Prostaglandin E2 (PGE2) enables precise modulation of GPCR signaling in inflammation and gastrointestinal protection assays. This guide translates bench-proven workflows, troubleshooting strategies, and comparative insights for maximizing data fidelity with APExBIO’s high-purity PGE2.

• Caspase-3 Colorimetric Assay Kit: Technical Protocol & QC Gu

  2026-04-21

  The Caspase-3 Colorimetric Assay Kit enables quantitative detection of DEVD-dependent caspase-3 activity, supporting apoptosis assays and caspase signaling pathway studies. It is best suited for rapid and sensitive caspase activity measurement in cell lysates, especially for research in apoptosis and neurodegeneration. The kit is not intended for in vivo or single-cell applications.

• CF10 and EdU Synergistically Induce Telomere Attrition in CR

  2026-04-21

  This study demonstrates that the fluoropyrimidine polymer CF10, when combined with 5-ethynyl-2′-deoxyuridine (EdU), induces pronounced telomere attrition and mitotic catastrophe in colorectal cancer cells. These findings reveal a mechanistically distinct synergy from traditional thymidylate synthase inhibition, providing new avenues for targeting cancer cell proliferation and genomic stability.

• EdU Imaging Kits (488): High-Precision Cell Cycle Quantifica

  2026-04-20

  Explore how EdU Imaging Kits (488) unlock unprecedented accuracy in measuring S-phase DNA synthesis and cell proliferation. This article uniquely integrates mechanistic insights with advanced oncology applications, distinguishing it from existing EdU kit content.

466 records 21/32 page Previous Next First page 上5页 2122232425 下5页 Last page